8-[6-[3-(AMINO)PROPOXY]-3-PYRIDYL]-1 -ISOPROPYL-IMIDAZO[4,5-C]QUINOLIN-2-ONE DERIVATIVES AS SELECTIVE MODULATORS OF ATAXIA TELANGIECTASIA MUTATED (ATM) KINASE FOR THE TREATMENT OF CANCER
PIKE, Kurt, Gordon,BARLAAM, Bernard, Christophe,HUNT, Thomas, Anthony,EATHERTON, Andrew, John
申请号：
EP16770461
公开号：
EP3350180A1
申请日:
2016.09.15
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
and pharmaceutically acceptable salts thereof, where R1, R2, R3, R4 and R5 have any of the meanings defined herein. The specification also relates to the use of compounds of Formula (I) and salts thereof to treat or prevent ATM mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising substituted imidazo[4,5-c]quinolin-2-one compounds and pharmaceutically acceptable salts thereof kits comprising such compounds and salts methods of manufacture of such compounds and salts and intermediates useful in such manufacture.
